Free shipping from 69,00 €
Get free shipping with a minimum spend of 69,00 €. Or by purchasing one of the selected products. Discover them now!
Reactine 6 tablets for the treatment of allergic rhinitis 5 mg + 120 mg - prolonged-release
-
6 Tablets€6.28
-
14 TabletsNot available
Information on returns and shipments
Payment methods
Medicines authorized by the Ministry of Health
REACTINE 5 MG + 120 MG PROLONGED RELEASE TABLETS
Pharmacotherapeutic category
Nasal decongestants for systemic use.
Active ingredients
Cetirizine dihydrochloride; pseudoephedrine hydrochloride.
Excipients
First layer excipients: hypromellose, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate. Second layer excipients: lactose, microcrystalline cellulose, sodium crosscaramel, colloidal anhydrous silica, magnesium stearate. Coating excipients: opadry Y-1-7000 white (methocel E5, premium (hypromellose) (E 464), titanium dioxide (E 171), macrogol 400).
Indications
Short-term symptomatic treatment of seasonal and/or perennial allergic rhinitis with nasal congestion and hypersecretion, nasal and/or ocular itching, sneezing and lacrimation.
Contraindications/side effects
Hypersensitivity to the active substance, to any of the excipients listed, to hydroxyzine or piperazine derivatives; severe renal insufficiency (patients with creatinine clearance less than 10 ml/min); severe hypertension; severe coronary artery disease; patients who are being treated or who have been treated in the previous two weeks with monoamine oxidase inhibitors; increased intraocular pressure; urinary retention; children under 12 years; pregnancy and breastfeeding.
Dosage
Adults and children 12 years and older: one tablet twice a day, one in the morning and one in the evening, to be taken without chewing during or between meals. The duration of treatment should not exceed the period of acute symptoms and in any case should not be prolonged beyond 7 days. After 7 days of therapy, continue treatment with cetirizine alone. Patients with renal impairment: the dose should be halved in patients with renal insufficiency. Patients with hepatic impairment: the dose should be halved in patients with hepatic insufficiency. Paediatric population: the medicine is contraindicated in children under 12 years of age.
Storage
No special storage precautions.
Price Trend
This product has been on sale since 25/09/2017
In the last 30 days, the product's lowest price was 5,47 €